How to modify 7-azaindole to form cytotoxic Pt(II) complexes: highly in vitro anticancer effective cisplatin derivatives involving halogeno-substituted 7-azaindole

. 2012 Oct ; 115 () : 57-63. [epub] 20120524

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid22922312

The platinum(II) dichlorido and oxalato complexes of the general formula cis-[PtCl(2)(nHaza)(2)] (1-3) [Pt(ox)(nHaza)(2)] (4-6) involving 7-azaindole halogeno-derivatives (nHaza) were prepared and thoroughly characterized. A single-crystal X-ray analysis of cis-[PtCl(2)(3ClHaza)(2)]·DMF (1·DMF; 3ClHaza symbolizes 3-chloro-7-azaindole) revealed a distorted square-planar arrangement with both the 3ClHaza molecules coordinated through their N7 atoms in a cis fashion. In vitro cytotoxicity of the complexes was evaluated by an MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay against the HOS (osteosarcoma), MCF7 (breast adenocarcinoma) and LNCaP (prostate adenocarcinoma) human cancer cell lines. The dichlorido complexes 1-3 (IC(50)=3.8, 3.9, and 2.5 μM, respectively) showed significantly higher in vitro anticancer effect against HOS as compared with cisplatin, whose IC(50)=37.7 μM. The biological effect of cisplatin against MCF7 (IC(50)=24.5 μM) and LNCaP (IC(50)=3.8 μM) was also exceeded by 1-3 (except for 2 against LNCaP), but the difference can be classified as significant only in the case of 1 (IC(50)=3.4 μM) and 3 (IC(50)=2.0 μM) against MCF7. The molecular pharmacological studies (RNA synthesis by T7 RNA polymerase in vitro) proved that 1-3 bind to DNA in a similar manner as cisplatin, since the RNA synthesis products of 1-3 and cisplatin showed a similar sequence profile of major bands.

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

In vitro anticancer active cis-Pt(II)-diiodido complexes containing 4-azaindoles

. 2019 Mar ; 24 (2) : 257-269. [epub] 20190214

In Vitro Antitumor Active Gold(I) Triphenylphosphane Complexes Containing 7-Azaindoles

. 2016 Dec 11 ; 17 (12) : . [epub] 20161211

Platinum(II) Iodido Complexes of 7-Azaindoles with Significant Antiproliferative Effects: An Old Story Revisited with Unexpected Outcomes

. 2016 ; 11 (12) : e0165062. [epub] 20161201

Organometallic Half-Sandwich Dichloridoruthenium(II) Complexes with 7-Azaindoles: Synthesis, Characterization and Elucidation of Their Anticancer Inactivity against A2780 Cell Line

. 2015 ; 10 (11) : e0143871. [epub] 20151125

Highly and Broad-Spectrum In Vitro Antitumor Active cis-Dichloridoplatinum(II) Complexes with 7-Azaindoles

. 2015 ; 10 (8) : e0136338. [epub] 20150826

Potentiating effect of UVA irradiation on anticancer activity of Carboplatin derivatives involving 7-azaindoles

. 2015 ; 10 (4) : e0123595. [epub] 20150415

Gold(I) complexes of 9-deazahypoxanthine as selective antitumor and anti-inflammatory agents

. 2014 ; 9 (10) : e109901. [epub] 20141015

Synthesis, characterization and in vitro antitumor activity of platinum(II) oxalato complexes involving 7-azaindole derivatives as coligands

. 2014 Jul 25 ; 19 (8) : 10832-44. [epub] 20140725

Pharmacological and molecular effects of platinum(II) complexes involving 7-azaindole derivatives

. 2014 ; 9 (3) : e90341. [epub] 20140306

4-aminobenzoic acid-coated maghemite nanoparticles as potential anticancer drug magnetic carriers: a case study on highly cytotoxic Cisplatin-like complexes involving 7-azaindoles

. 2014 Jan 28 ; 19 (2) : 1622-34. [epub] 20140128

N6-benzyladenosine derivatives as novel N-donor ligands of platinum(II) dichlorido complexes

. 2013 Jun 14 ; 18 (6) : 6990-7003. [epub] 20130614

Insight into the toxic effects of cis-dichloridoplatinum(II) complexes containing 7-azaindole halogeno derivatives in tumor cells

. 2013 Jun ; 18 (5) : 579-89. [epub] 20130515

5-Bromo-1H-pyrrolo-[2,3-b]pyridine

. 2013 Mar 01 ; 69 (Pt 3) : o381. [epub] 20130216

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...